Compare BHST & JHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BHST | JHS |
|---|---|---|
| Founded | 2007 | 1973 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Finance Companies |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.2M | 137.3M |
| IPO Year | N/A | N/A |
| Metric | BHST | JHS |
|---|---|---|
| Price | $5.77 | $11.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 37.2K | 32.8K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $32,720,000.00 | N/A |
| Revenue This Year | $116.40 | N/A |
| Revenue Next Year | $55.91 | N/A |
| P/E Ratio | ★ N/A | $553.50 |
| Revenue Growth | ★ 45.88 | N/A |
| 52 Week Low | $4.72 | $9.76 |
| 52 Week High | $12.80 | $11.25 |
| Indicator | BHST | JHS |
|---|---|---|
| Relative Strength Index (RSI) | 55.59 | 51.90 |
| Support Level | $4.80 | $11.75 |
| Resistance Level | $5.45 | $11.86 |
| Average True Range (ATR) | 0.41 | 0.09 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 71.86 | 39.02 |
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
John Hancock Income Securities Trust is a United States-based closed-end diversified management investment company. Its main objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.